Company Quick10K Filing
CoStar Group
10-Q 2021-03-31 Filed 2021-04-28
10-K 2020-12-31 Filed 2021-02-24
10-Q 2020-09-30 Filed 2020-10-28
10-Q 2020-06-30 Filed 2020-07-29
10-Q 2020-03-31 Filed 2020-04-29
10-K 2019-12-31 Filed 2020-02-26
10-Q 2019-09-30 Filed 2019-10-23
10-Q 2019-06-30 Filed 2019-07-24
10-Q 2019-03-31 Filed 2019-04-24
10-K 2018-12-31 Filed 2019-02-28
10-Q 2018-09-30 Filed 2018-10-24
10-Q 2018-06-30 Filed 2018-07-25
10-Q 2018-03-31 Filed 2018-04-25
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-10-26
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-24
10-Q 2016-09-30 Filed 2016-10-27
10-Q 2016-06-30 Filed 2016-07-28
10-Q 2016-03-31 Filed 2016-04-28
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-10-29
10-Q 2015-06-30 Filed 2015-07-30
10-Q 2015-03-31 Filed 2015-04-30
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-10-30
10-Q 2014-06-30 Filed 2014-07-25
10-Q 2014-03-31 Filed 2014-04-24
10-K 2013-12-31 Filed 2014-02-20
10-Q 2013-09-30 Filed 2013-10-24
10-Q 2013-06-30 Filed 2013-07-24
10-Q 2013-03-31 Filed 2013-04-25
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-10-25
10-Q 2012-06-30 Filed 2012-07-26
10-Q 2012-03-31 Filed 2012-04-27
10-K 2011-12-31 Filed 2012-02-23
10-Q 2011-09-30 Filed 2011-10-27
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-04-29
10-K 2010-12-31 Filed 2011-02-25
10-Q 2010-09-30 Filed 2010-10-22
10-Q 2010-06-30 Filed 2010-07-23
10-Q 2010-03-31 Filed 2010-04-23
10-K 2009-12-31 Filed 2010-02-26
8-K 2021-02-23
8-K 2021-02-16
8-K 2021-01-04
8-K 2020-10-27
8-K 2020-09-27
8-K 2020-07-28
8-K 2020-07-01
8-K 2020-06-24
8-K 2020-06-03
8-K 2020-05-26
8-K 2020-05-13
8-K 2020-04-29
8-K 2020-04-28
8-K 2020-03-25
8-K 2020-02-25
8-K 2020-02-11
8-K 2019-12-12
8-K 2019-10-22
8-K 2019-09-30
8-K 2019-09-30
8-K 2019-07-23
8-K 2019-06-05
8-K 2019-04-23
8-K 2019-02-26
8-K 2018-10-23
8-K 2018-07-24
8-K 2018-06-06
8-K 2018-04-23
8-K 2018-02-21
8-K 2018-01-17

CoStar Group Financials

CSGP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5485515455491031291561671902232562234454865275423523764224624645225675725656231,2119319661,0721,1001,2331,2981,390
Accounts Receivable13191716202116242523213240393946545140474647495052616169708289939691
Inventory
PP&E373776394343914950561015765711237985881458687851638686841838385821938685108
Assets7587657717741,1411,1551,1651,1841,1971,2301,2571,2452,0462,0642,0842,1002,0742,0912,0802,1062,1072,1532,1852,1952,2202,2812,8733,0953,1233,2073,3133,5483,6213,715
Accounts Payable4464646446548897714107141011171711989106878
Long-Term Debt17317117116616215815314939539038538037537036536034534534531031031000
Liabilities112115112107339339339333330331329315575572570585568581536541521534531511503518222294272279291420417416
Stockholders' Equity6466506596678038168268518678999289301,4711,4921,5141,5151,5061,5101,5441,5651,5861,6191,6541,6841,7171,7622,6512,8012,8512,9283,0223,1293,2043,299
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue626466699096100104109112116119154153156159171189193200207213218227237248254274297306316328344353
Cost of Revenue22212224313131343532323439414345455445434342465155555862677268717271
Gross Profit404344445765697077818485108112113114126135148157164170172175182192196211230233247257272282
R&D
SG&A3034313046424457464647537466689512211289103111106100110126109119129151128128161147
Tax1134603-257765871-7310111014161342144241426131720
Net Income3255-475-2811131081314-6-15-523171623302222344452445984856379
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating46624263011313135-750534830-343624834615265316871734610114885116
Cash Investing-2-14-2-6351-5-5-4-6-4-4-591-9-2-11-178-14-120-14-4-6-20-38-10-5-349-7-6-9-19-30
Cash Financing02-1165-125-481-22762-2-5-4-9-4-3-8-181-1-40-1-0521-5-310-7-15